These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9051403)

  • 1. The treatment of type II diabetes in Texas. Current issues for managed care and employers.
    Davidson JA
    Diabetes Care; 1997 Mar; 20(3):446-51. PubMed ID: 9051403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do-it-yourself managed care. Case study I: Randall's Medical Network. Case study II: Hershey's Managed Care Plan.
    Profiles Healthc Mark; 1993; (52):18-27. PubMed ID: 10125016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed care: past evidence and potential trends.
    Miller RH; Luft HS
    Front Health Serv Manage; 1993; 9(3):3-37; discussion 53-4. PubMed ID: 10124422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best practices in the care of type 2 diabetes: integrating clinical needs with medical policy and practice.
    Bunn WB
    Am J Manag Care; 2009 Sep; 15(9 Suppl):S263-8. PubMed ID: 19817515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality standards and incentives in managed care organizations' specialty contracts for behavioral health.
    Hodgkin D; Horgan CM; Garnick DW; Merrick EL
    J Ment Health Policy Econ; 2002 Jun; 5(2):61-9. PubMed ID: 12529562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing diabetes management: managed care strategies.
    Tzeel EA
    Am J Manag Care; 2013 Jun; 19(8 Suppl):S149-54. PubMed ID: 23844831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care.
    Killilea T
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S441-9. PubMed ID: 12408407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCOs: cost centers or profit partners for employers?
    MacStravic S
    Manag Care Q; 2003; 11(4):1-4. PubMed ID: 15283436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with quality monitoring for Medicaid managed care: perceptions of institutional and private providers in New York City.
    Fairbrother G; Friedman S; Butts GC; Cukor J; Tassi A
    J Urban Health; 2000 Dec; 77(4):573-91. PubMed ID: 11194303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of managed care to control health care costs: how much is enough?
    Feldman R
    J Health Care Finance; 2000; 26(3):15-25. PubMed ID: 10728482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of asthma care in managed care organizations: results from the Chicago Asthma Surveillance Initiative.
    Nelson SG; Grant EN; Trubitt MJ; Foggs MB; Weiss KB
    Chest; 1999 Oct; 116(4 Suppl 1):173S-178S. PubMed ID: 10532480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jury still out on extent of employers' cost savings under managed care. An AMA policy research perspective.
    J La State Med Soc; 1994 Aug; 146(8):355-7. PubMed ID: 7930867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II diabetes mellitus clinical guidelines at primary health care level. A SEMDSA Consensus Document, 1997, in association with DESSA, ADSA.
    S Afr Med J; 1997 Apr; 87(4 Pt 3):493-512. PubMed ID: 9199638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to prostate cancer by managed care organizations.
    Bennett CL; Buchner DA; Ullman M
    Urology; 1997 Jul; 50(1):79-86. PubMed ID: 9218023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis: a payor's perspective on epinephrine autoinjectors.
    Dunn JD; Sclar DA
    Am J Med; 2014 Jan; 127(1 Suppl):S45-50. PubMed ID: 24384137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The managed-care perspective for improving quality.
    van Amerongen D
    Oncology (Williston Park); 2000 Nov; 14(11A):108-9. PubMed ID: 11195404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive managed care evaluation.
    Bushick B
    Benefits Q; 1992; 8(2):36-40. PubMed ID: 10118726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of normative social forces on managed care organizations: implications for strategic management.
    Kirby EG; Sebastian JG
    J Healthc Manag; 1998; 43(1):81-95; discussion 96-8. PubMed ID: 10178796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.